Cancer and Metastasis Reviews

Papers
(The H4-Index of Cancer and Metastasis Reviews is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Editorial Expression of Concern: Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer172
Immunotherapy for leptomeningeal disease from solid tumors: current clinical outcomes and future opportunities166
The impact of tumor microenvironment: unraveling the role of physical cues in breast cancer progression134
The functions and modifications of tRNA-derived small RNAs in cancer biology96
Clonal tracking in cancer and metastasis88
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective73
New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions69
CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanisms67
The role of microbiome in pancreatic cancer62
Obesity and cancer57
Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?47
Regulation of dormancy during tumor dissemination: the role of the ECM47
The paradoxical role of inositol in cancer: a consequence of the metabolic state of a tumor46
Progression and metastasis of small cell lung carcinoma: the role of the PI3K/Akt/mTOR pathway and metabolic alterations46
CAR T-cell therapy to treat multiple myeloma: current state and future directions46
Targeting lipid metabolism in cancer: neuroblastoma46
The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer44
Cell-cell interactions mediating primary and metastatic breast cancer dormancy43
TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond41
Healthcare disparities, screening, and molecular testing in the changing landscape of non–small cell lung cancer in the United States: a review40
Correction to: Cutting the edge between cancerogenesis and organogenesis of the pancreatic endocrine lineage allocation—comprehensive review of the genes Synaptotagmin 13 and 533041C22 Rik in epitheli39
KISS1 metastasis suppressor in tumor dormancy: a potential therapeutic target for metastatic cancers?36
p73 isoforms meet evolution of metastasis36
Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives35
Biography—Mathieu Boissan, Pharm.D., Ph.D35
A multidisciplinary perspective on the complex interactions between sleep, circadian, and metabolic disruption in cancer patients35
Preface35
Targeting microRNAs as a promising anti-cancer therapeutic strategy against traffic-related air pollution-mediated lung cancer34
LGR5: An emerging therapeutic target for cancer metastasis and chemotherapy resistance33
Neuropeptide Y in cancer—biological functions and potential clinical implications33
The multifaceted mechanisms of malignant glioblastoma progression and clinical implications31
Biographies31
0.084043979644775